Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal
Harrison E. Saull, Cher Y. Enderby, Thomas A. Gonwa, Hani M. Wadei
Dive into the research topics of 'Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal'. Together they form a unique fingerprint.